Non-secretory multiple myeloma: Diagnosis and management

被引:12
作者
Charlinski, Grzegorz [1 ,2 ]
Jurczyszyn, Artur [3 ]
机构
[1] Univ Warmia & Mazury, Dept Internal Med, Olsztyn, Poland
[2] Minist Interior & Adm Hosp, Dept Hematol, Warmian Masurian Canc Ctr, Olsztyn, Poland
[3] Jagiellonian Univ Coll Med, Fac Med, Plasma Cell Dyscrasias Ctr, Dept Hematol, Krakow, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2022年 / 31卷 / 01期
关键词
diagnosis; management; non-secretory multiple myeloma; IMAGING TECHNIQUES; TRANSPLANTATION; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; CRITERIA; OUTCOMES; DISEASE; CHAIN; AGE;
D O I
10.17219/acem/141455
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. One criterion for the diagnosis of MM is serum and/or urine monoclonal protein produced by clonal plasmocytes. However, about 1-2% of MM cases do not have monoclonal protein. If other diagnostic criteria are present, the possibility of a di-agnosis of non-secretory MM should be considered. As the different types of non-secretory MM depend on the underlying cause, the current definition is considered insufficient. Currently, both the diagnosis and treatment of non-secretory MM are the same as those of secretory MM. Due to the rarity of non-secretory MM, most findings are from retrospective studies on small groups of patients and case reports. The method of monitoring the effectiveness of MM treatment remains a problem, as it is usually based on the assessment of the percentage of clonal plasma cells in the bone marrow and imaging studies.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
[21]   Diagnosis and management of multiple myeloma [J].
Ely, SA .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) :1194-1195
[22]   Management of multiple myeloma in younger patients [J].
Strifler, S. ;
Einsele, H. .
ONKOLOGE, 2018, 24 (08) :604-608
[23]   Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review [J].
Zhang, Yanjie ;
Pan, Juan ;
Kang, Haixin ;
Peng, Shuotao ;
Tung, Tao-Hsin ;
Shen, Bo .
ANNALS OF MEDICINE, 2024, 56 (01)
[24]   Multiple Myeloma: Diagnosis and Treatment [J].
Michels, Thomas C. ;
Petersen, Keith E. .
AMERICAN FAMILY PHYSICIAN, 2017, 95 (06) :373-383
[25]   Updates to Management of Multiple Myeloma [J].
Callander, Natalie S. ;
Mangan, Patricia A. ;
Kumar, Shaji K. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2025, 23
[26]   Multiple Visceral Resection for Giant Non-Secretory Adrenocortical Carcinoma in an Elderly Patient: A Case Report [J].
Bacalbasa, Nicolae ;
Terzea, Dana ;
Jianu, Valeria ;
Marcu, Madalina ;
Stoica, Claudia ;
Balescu, Irina .
ANTICANCER RESEARCH, 2015, 35 (04) :2169-2174
[27]   Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter? [J].
Kothari, Shalin ;
Hillengass, Jens ;
McCarthy, Philip L. ;
Holstein, Sarah A. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (01) :39-46
[28]   Non secretory multiple myeloma involving the maxilla: Report of a case with update of biology and new approaches to management [J].
Gray, ST ;
Antunovic, DM ;
White, AE .
ORAL ONCOLOGY, 1997, 33 (02) :136-140
[29]   Updates to the guidelines for the diagnosis and management of multiple myeloma [J].
Pratt, Guy ;
Jenner, Matthew ;
Owen, Roger ;
Snowden, John A. ;
Ashcroft, John ;
Yong, Kwee ;
Feyler, Sylvia ;
Morgan, Gareth ;
Cavenagh, Jamie ;
Cook, Gordon ;
Low, Eric ;
Stern, Simon ;
Behrens, Judith ;
Davies, Faith ;
Bird, Jennifer .
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) :131-133
[30]   Ixazomib in the management of relapsed multiple myeloma [J].
Touzeau, Cyrille ;
Moreau, Philippe .
FUTURE ONCOLOGY, 2018, 14 (20) :2012-2019